SCARPA, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.684
AS - Asia 2.132
EU - Europa 1.162
AF - Africa 549
SA - Sud America 467
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 30
Totale 8.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.379
SG - Singapore 833
CN - Cina 333
HK - Hong Kong 314
BR - Brasile 262
IT - Italia 177
VN - Vietnam 141
NL - Olanda 111
DE - Germania 93
FI - Finlandia 62
FR - Francia 58
RU - Federazione Russa 54
GB - Regno Unito 53
PL - Polonia 45
SE - Svezia 43
AR - Argentina 41
ES - Italia 32
IN - India 32
MX - Messico 29
ZA - Sudafrica 29
EC - Ecuador 28
IE - Irlanda 28
PE - Perù 27
AT - Austria 26
ID - Indonesia 25
CA - Canada 23
MA - Marocco 23
CI - Costa d'Avorio 22
JM - Giamaica 21
KG - Kirghizistan 21
PA - Panama 21
BO - Bolivia 20
GT - Guatemala 20
IQ - Iraq 20
IR - Iran 20
JP - Giappone 20
KR - Corea 20
LY - Libia 20
AO - Angola 19
CO - Colombia 19
HN - Honduras 19
LU - Lussemburgo 19
SI - Slovenia 19
SO - Somalia 19
AU - Australia 18
BA - Bosnia-Erzegovina 18
MU - Mauritius 18
UZ - Uzbekistan 18
BD - Bangladesh 17
BG - Bulgaria 17
DZ - Algeria 17
PY - Paraguay 17
SA - Arabia Saudita 17
TH - Thailandia 17
UY - Uruguay 17
AL - Albania 16
BB - Barbados 16
BJ - Benin 16
BY - Bielorussia 16
CH - Svizzera 16
CR - Costa Rica 16
GA - Gabon 16
GE - Georgia 16
GR - Grecia 16
HU - Ungheria 16
KE - Kenya 16
NE - Niger 16
NP - Nepal 16
NZ - Nuova Zelanda 16
PH - Filippine 16
RS - Serbia 16
TR - Turchia 16
UA - Ucraina 16
XK - ???statistics.table.value.countryCode.XK??? 16
YT - Mayotte 16
ZW - Zimbabwe 16
AZ - Azerbaigian 15
BE - Belgio 15
CL - Cile 15
IL - Israele 15
LC - Santa Lucia 15
ML - Mali 15
PK - Pakistan 15
RW - Ruanda 15
SK - Slovacchia (Repubblica Slovacca) 15
UG - Uganda 15
CV - Capo Verde 14
CW - ???statistics.table.value.countryCode.CW??? 14
CZ - Repubblica Ceca 14
DJ - Gibuti 14
DK - Danimarca 14
EG - Egitto 14
HR - Croazia 14
LA - Repubblica Popolare Democratica del Laos 14
MG - Madagascar 14
MZ - Mozambico 14
NC - Nuova Caledonia 14
PS - Palestinian Territory 14
PT - Portogallo 14
TJ - Tagikistan 14
Totale 7.513
Salva come PNG Salva come JPEG
Città #
Fairfield 519
Singapore 481
Ashburn 467
Hong Kong 300
Chandler 250
Woodbridge 205
Seattle 201
Houston 196
Cambridge 180
Beijing 132
Santa Clara 131
Wilmington 128
Ann Arbor 75
Boardman 74
Los Angeles 57
San Diego 55
Ho Chi Minh City 52
Medford 41
Princeton 40
Frankfurt am Main 35
New York 35
Hanoi 34
Helsinki 33
Des Moines 31
Padova 29
Munich 27
Roxbury 27
Chicago 26
Bytom 24
Hefei 22
Abidjan 20
Bishkek 20
Buffalo 19
Dublin 19
Panama City 19
Tashkent 18
Vienna 18
Lima 17
Milan 17
Dallas 16
Libreville 16
Nanjing 16
Bamako 15
Bridgetown 15
Castries 15
Kampala 15
São Paulo 15
Baku 14
Cotonou 14
Dushanbe 14
Kigali 14
Kingston 14
Lappeenranta 14
Lusaka 14
Nairobi 14
Noumea 14
Tripoli 14
Accra 13
Amsterdam 13
Dakar 13
Harare 13
Luanda 13
Reykjavik 13
San José 13
Amman 12
Antananarivo 12
Cape Town 12
Guatemala City 12
Johannesburg 12
Luxembourg 12
Montevideo 12
Niamey 12
Pristina 12
Sofia 12
Vientiane 12
Warsaw 12
Athens 11
Djibouti 11
Guayaquil 11
Havana 11
Managua 11
Phnom Penh 11
Riga 11
Salt Lake City 11
Stockholm 11
Tokyo 11
Ljubljana 10
Maputo 10
Nassau 10
Praia 10
Quito 10
San Juan 10
San Pedro Sula 10
Tbilisi 10
Ulan Bator 10
Verona 10
Willemstad 10
Aprilia 9
Auckland 9
Baghdad 9
Totale 4.819
Salva come PNG Salva come JPEG
Nome #
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 237
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 237
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 189
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 188
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 187
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 183
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 176
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma 176
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 172
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 170
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 169
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 167
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 166
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: A systematic review and meta-Analysis 157
Prognostic impact of proliferation for resected early stage ‘pure’ invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 149
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 144
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study 144
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 141
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 141
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 139
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 139
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis 139
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 137
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: Correlation of expression, chromosomal status and epigenetic changes 137
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 136
Inflammatory and tumor-like lesions of the pancreas 135
Malignant epithelial/exocrine tumors of the pancreas 130
New genomic landscapes and therapeutic targets for biliary tract cancers 127
Comparative Lesions Analysis Through a Targeted Sequencing Approach 126
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice 125
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 116
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 115
PBRM1 loss is a late event during the development of cholangiocarcinoma 112
Genomic Characterization of Biliary Tract Cancers Identifies Driver Genes and Predisposing Mutations 111
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 110
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 109
Exosomal miRNA signatures of pancreatic lesions 108
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 107
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 105
Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells 104
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 104
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 102
Genomic characterization of hepatoid tumors: context matters 101
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 97
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 95
Molecular biology of neuroendocrine tumors 95
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 93
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 92
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 90
Real-world data on NGS diagnostics: A survey from the Italian Society of Pathology (SIAPeC) NGS Network 90
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 89
European evidence-based guidelines on pancreatic cystic neoplasms 87
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 87
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 85
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution 82
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 81
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 80
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 77
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 75
Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas 74
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 70
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 69
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 63
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 63
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 60
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 58
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 58
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 52
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 49
Totale 8.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.073
article - articoli 28.646
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 427
Totale 58.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 9 45 57 55 124 81 17
2021/2022635 19 86 94 36 30 8 66 63 32 11 52 138
2022/2023466 87 58 11 64 58 47 2 34 55 25 19 6
2023/2024329 6 39 43 43 18 38 35 4 16 11 40 36
2024/20251.745 15 119 89 46 202 52 93 158 119 140 287 425
2025/20263.547 303 421 941 1.142 645 95 0 0 0 0 0 0
Totale 8.178